Protected for Decades, Vulnerable in Later Years: The Quiet Collapse of Senior Vaccination Rates

For much of adult life, vaccines tend to fade into the background. A tetanus booster here, a flu shot there — and for many Americans, that sporadic approach feels sufficient. But by the time a person reaches their mid-sixties, the stakes of skipping or delaying recommended immunizations shift dramatically. The immune system becomes less responsive with age, chronic conditions accumulate, and the consequences of infections that a younger body might shrug off can become life-altering or fatal.

And yet, data from the Centers for Disease Control and Prevention consistently shows that vaccination rates among adults 65 and older lag well behind national targets — and in some cases, behind rates among younger adults. This is not a minor statistical footnote. It represents a substantial and largely preventable public health failure affecting tens of millions of people.

Understanding why this gap exists requires looking beyond individual choice and into the structural, cultural, and clinical realities that shape how older Americans engage with preventive healthcare.

The Paradox of High Risk and Low Uptake

Adults over 65 account for a disproportionate share of hospitalizations and deaths from diseases that vaccines can prevent. Influenza, pneumococcal pneumonia, shingles, and COVID-19 all follow this pattern — striking older adults with a severity that younger populations rarely experience. Respiratory syncytial virus (RSV), for which vaccines are now available for older adults, is another example of a pathogen that can be devastating in later life.

Given this vulnerability, one might expect that seniors would be among the most vaccinated groups in the country. The opposite is often true. Influenza vaccination rates among adults 65 and older, while higher than in some younger cohorts, still fall short of the 70 percent target set by Healthy People 2030. For shingles, which affects roughly one in three Americans over a lifetime and disproportionately strikes those over 50, coverage among eligible older adults remains inadequate despite the availability of a highly effective two-dose vaccine. The pneumococcal vaccine series, updated in recent years to include newer formulations, is similarly underutilized.

Outdated Beliefs About Immunity and Aging

One of the most persistent barriers is a set of beliefs that many older adults absorbed decades ago and have never had reason to revisit. Chief among these is the assumption that vaccines are primarily a childhood concern — that once the foundational series of shots is complete, one's immunological obligations are largely fulfilled.

This belief is medically outdated. Immunity from certain vaccines wanes over time, and the aging immune system — a process researchers call immunosenescence — becomes progressively less capable of mounting robust responses to pathogens. This means that older adults not only face greater exposure risk in many settings, but also possess a diminished biological defense when exposure occurs. Vaccines calibrated for older immune systems, such as the high-dose and adjuvanted influenza formulations recommended for adults 65 and older, exist precisely because standard doses may not generate sufficient protection in this population.

Yet many older adults are simply unaware that their vaccination needs have evolved. A 70-year-old who received a pneumococcal vaccine years ago may not know that updated recommendations call for additional doses using newer vaccine types. A patient who had chickenpox as a child may not understand that the varicella-zoster virus can reactivate decades later as shingles — and that vaccination significantly reduces that risk.

Fragmented Care and the Communication Gap

The structure of American healthcare itself contributes to the problem. Older adults are more likely than younger patients to see multiple providers — a primary care physician, a cardiologist, an orthopedist, a neurologist — and in this fragmented environment, preventive care can fall through the cracks. Each specialist tends to focus on the condition within their domain, and vaccination status is rarely anyone's explicit priority.

Electronic health records, while increasingly common, do not always communicate seamlessly across different health systems or provider networks. A vaccine administered at a pharmacy may not appear in a physician's records. A dose given years ago at a different practice may be invisible to a new provider. The result is a patchwork of incomplete information that makes it difficult for both patients and clinicians to assess what has been received and what remains outstanding.

Primary care physicians are best positioned to coordinate vaccination for older adults, but appointment times are often short and dominated by the management of chronic conditions. Vaccination, perceived as routine and non-urgent, may not surface in a fifteen-minute visit focused on blood pressure, diabetes management, or joint pain.

The Role of Cost and Access

Financial barriers, while less acute for Medicare beneficiaries than for uninsured younger adults, are not entirely absent. Medicare Part D covers most recommended vaccines, but navigating coverage details — which plan covers which vaccine, what the cost-sharing structure looks like — can be confusing, particularly for individuals managing multiple prescriptions and benefits across different parts of Medicare.

For older adults in rural areas, geographic distance to pharmacies or clinics adds another layer of friction. Transportation challenges, mobility limitations, and the logistics of arranging care can make even a brief vaccination appointment feel prohibitively complicated.

What Evidence-Based Practice Recommends

The Advisory Committee on Immunization Practices (ACIP), which advises the CDC on vaccine recommendations, provides clear guidance for adults 65 and older. Current recommendations include annual influenza vaccination using a high-dose or adjuvanted formulation, two doses of the recombinant zoster vaccine (Shingrix) for shingles prevention, pneumococcal vaccination using updated schedules that may involve more than one vaccine type, COVID-19 vaccination and updated boosters as recommended, and RSV vaccination for adults 60 and older, based on a shared clinical decision-making conversation with a provider.

For adults who are unsure of their vaccination history, the CDC's immunization records guidance and state immunization information systems can help reconstruct what has been received.

Closing the Gap Requires More Than Awareness

Public health campaigns aimed at older adults have historically focused on flu shots, with mixed results. Expanding awareness to the full recommended schedule — and doing so through trusted messengers such as primary care physicians, pharmacists, and community health workers — is essential.

Healthcare systems can support this effort by building vaccination review into annual wellness visits, using electronic reminders to flag patients who are overdue, and training staff to proactively address common concerns about vaccine safety in older populations.

For older adults themselves, the most important step is initiating a direct conversation with a primary care provider about current vaccination status. Bringing a list of previously received vaccines, asking specifically about age-appropriate recommendations, and following through on any doses identified as outstanding can meaningfully reduce the risk of a preventable illness.

The vaccines exist. The evidence supporting their use in older adults is robust. What remains is the work of ensuring that the people who need them most are actually receiving them — before a preventable disease makes the case in the most difficult way possible.